164 related articles for article (PubMed ID: 21150880)
1. Tumour-specific methylation of PTPRG intron 1 locus in sporadic and Lynch syndrome colorectal cancer.
van Roon EH; de Miranda NF; van Nieuwenhuizen MP; de Meijer EJ; van Puijenbroek M; Yan PS; Huang TH; van Wezel T; Morreau H; Boer JM
Eur J Hum Genet; 2011 Mar; 19(3):307-12. PubMed ID: 21150880
[TBL] [Abstract][Full Text] [Related]
2. Aberrant DNA methylation of PTPRG as one possible mechanism of its under-expression in CML patients in the State of Qatar.
Ismail MA; Samara M; Al Sayab A; Alsharshani M; Yassin MA; Varadharaj G; Vezzalini M; Tomasello L; Monne M; Morsi H; Qoronfleh MW; Zayed H; Cook R; Sorio C; Modjtahedi H; Al-Dewik NI
Mol Genet Genomic Med; 2020 Oct; 8(10):e1319. PubMed ID: 32700424
[TBL] [Abstract][Full Text] [Related]
3. Metastatic suppressor genes inactivated by aberrant methylation in gastric cancer.
Wang JF; Dai DQ
World J Gastroenterol; 2007 Nov; 13(43):5692-8. PubMed ID: 17963294
[TBL] [Abstract][Full Text] [Related]
4. Disruption of a -35 kb Enhancer Impairs CTCF Binding and
Liu Q; Thoms JAI; Nunez AC; Huang Y; Knezevic K; Packham D; Poulos RC; Williams R; Beck D; Hawkins NJ; Ward RL; Wong JWH; Hesson LB; Sloane MA; Pimanda JE
Clin Cancer Res; 2018 Sep; 24(18):4602-4611. PubMed ID: 29898989
[No Abstract] [Full Text] [Related]
5. Efficient molecular screening of Lynch syndrome by specific 3' promoter methylation of the MLH1 or BRAF mutation in colorectal cancer with high-frequency microsatellite instability.
Nakagawa H; Nagasaka T; Cullings HM; Notohara K; Hoshijima N; Young J; Lynch HT; Tanaka N; Matsubara N
Oncol Rep; 2009 Jun; 21(6):1577-83. PubMed ID: 19424639
[TBL] [Abstract][Full Text] [Related]
6. Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients.
Alemayehu A; Sebova K; Fridrichova I
Genes Chromosomes Cancer; 2008 Oct; 47(10):906-14. PubMed ID: 18618713
[TBL] [Abstract][Full Text] [Related]
7. Protein tyrosine phosphatase receptor type {gamma} is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemia.
Della Peruta M; Martinelli G; Moratti E; Pintani D; Vezzalini M; Mafficini A; Grafone T; Iacobucci I; Soverini S; Murineddu M; Vinante F; Tecchio C; Piras G; Gabbas A; Monne M; Sorio C
Cancer Res; 2010 Nov; 70(21):8896-906. PubMed ID: 20959494
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer.
McGivern A; Wynter CV; Whitehall VL; Kambara T; Spring KJ; Walsh MD; Barker MA; Arnold S; Simms LA; Leggett BA; Young J; Jass JR
Fam Cancer; 2004; 3(2):101-7. PubMed ID: 15340260
[TBL] [Abstract][Full Text] [Related]
9. PTPRG inhibition by DNA methylation and cooperation with RAS gene activation in childhood acute lymphoblastic leukemia.
Xiao J; Lee ST; Xiao Y; Ma X; Houseman EA; Hsu LI; Roy R; Wrensch M; de Smith AJ; Chokkalingam A; Buffler P; Wiencke JK; Wiemels JL
Int J Cancer; 2014 Sep; 135(5):1101-9. PubMed ID: 24496747
[TBL] [Abstract][Full Text] [Related]
10. Altered methylation at microRNA-associated CpG islands in hereditary and sporadic carcinomas: a methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)-based approach.
Pavicic W; Perkiö E; Kaur S; Peltomäki P
Mol Med; 2011; 17(7-8):726-35. PubMed ID: 21327300
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylation.
Greco SA; Chia J; Inglis KJ; Cozzi SJ; Ramsnes I; Buttenshaw RL; Spring KJ; Boyle GM; Worthley DL; Leggett BA; Whitehall VL
BMC Cancer; 2010 Sep; 10():494. PubMed ID: 20846368
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide DNA methylation profiles of low- and high-grade adenoma reveals potential biomarkers for early detection of colorectal carcinoma.
Fan J; Li J; Guo S; Tao C; Zhang H; Wang W; Zhang Y; Zhang D; Ding S; Zeng C
Clin Epigenetics; 2020 Apr; 12(1):56. PubMed ID: 32317010
[TBL] [Abstract][Full Text] [Related]
13. Distinct epigenetic domains separated by a CTCF bound insulator between the tandem genes, BLU and RASSF1A.
Chang JW; Hsu HS; Ni HJ; Chuang CT; Hsiung CH; Huang TH; Wang YC
PLoS One; 2010 Sep; 5(9):e12847. PubMed ID: 20877461
[TBL] [Abstract][Full Text] [Related]
14. Regulative Loop between β-catenin and Protein Tyrosine Receptor Type γ in Chronic Myeloid Leukemia.
Tomasello L; Vezzalini M; Boni C; Bonifacio M; Scaffidi L; Yassin M; Al-Dewik N; Takam Kamga P; Krampera M; Sorio C
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32225105
[TBL] [Abstract][Full Text] [Related]
15. Somatic hypermethylation of MSH2 is a frequent event in Lynch Syndrome colorectal cancers.
Nagasaka T; Rhees J; Kloor M; Gebert J; Naomoto Y; Boland CR; Goel A
Cancer Res; 2010 Apr; 70(8):3098-108. PubMed ID: 20388775
[TBL] [Abstract][Full Text] [Related]
16. Methyltransferase expression and tumor suppressor gene methylation in sporadic and familial colorectal cancer.
Joensuu EI; Nieminen TT; Lotsari JE; Pavicic W; Abdel-Rahman WM; Peltomäki P
Genes Chromosomes Cancer; 2015 Dec; 54(12):776-87. PubMed ID: 26305882
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer.
Hampel H; Pearlman R; Beightol M; Zhao W; Jones D; Frankel WL; Goodfellow PJ; Yilmaz A; Miller K; Bacher J; Jacobson A; Paskett E; Shields PG; Goldberg RM; de la Chapelle A; Shirts BH; Pritchard CC;
JAMA Oncol; 2018 Jun; 4(6):806-813. PubMed ID: 29596542
[TBL] [Abstract][Full Text] [Related]
18. CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.
Eldholm V; Haugen A; Zienolddiny S
Int J Cancer; 2014 May; 134(10):2305-13. PubMed ID: 24174344
[TBL] [Abstract][Full Text] [Related]
19. [Methylation of PTPRG gene and its regulation in gastric cancer].
Wang JF; Dai DQ
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):85-8. PubMed ID: 18646686
[TBL] [Abstract][Full Text] [Related]
20. Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer.
Nagasaka T; Koi M; Kloor M; Gebert J; Vilkin A; Nishida N; Shin SK; Sasamoto H; Tanaka N; Matsubara N; Boland CR; Goel A
Gastroenterology; 2008 Jun; 134(7):1950-60, 1960.e1. PubMed ID: 18435933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
